Tratamiento profiláctico de la migraña con flunaricina:¿5 o 10 mg? / Prophyllactic treatment of migraine with flunarizine: 5 mg or 10 mg?
Rev. neurol. (Ed. impr.)
; 33(1): 96-97, 1 jul., 2001.
Article
in Es
| IBECS
| ID: ibc-20811
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.1: Reduce maternal mortality
/
Arterial Hypertension
/
Cardiovascular Disease
/
Digestive System Diseases
/
Endocrine System Diseases
/
Epilepsy
/
Migraine
/
Other Respiratory Diseases
/
Sickle Cell Disorders
/
Skin Diseases
Database:
IBECS
Main subject:
Paraplegia
/
Porphobilinogen
/
Pregnancy Complications
/
Puerperal Disorders
/
Respiratory Insufficiency
/
Seizures
/
Sickle Cell Trait
/
Brain Edema
/
Tracheostomy
/
Calcium Channel Blockers
Type of study:
Diagnostic study
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
/
Pregnancy
Language:
Spanish
Journal:
Rev. neurol. (Ed. impr.)
Year:
2001
Document type:
Article
Institution/Affiliation country:
Hospital de Mataró/España